Stockreport
High Growth Tech Stocks To Watch This September 2024 [Yahoo! Finance]
Last gilead sciences, inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
Top 10 High Growth Tech Companies TG Therapeutics ?????? Sarepta Therapeutics ?????? Seojin SystemLtd ?????? Medley ?????? Scandion Oncology ?????? G1 Therapeutics ?????? KebNi ?????? Adveritas ?????? Adocia ?????? Travere Therapeutics ?????? Let's dive into some prime choices out of from the screener. Simply Wall St Growth Rating: ?????? Overview: Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes medicines addressing unmet medical needs globally, with a market cap of approximately $103.40 billion. Operations: Gilead Sciences focuses on the discovery, development, and commercialization of innovative medicines, generating approximately $27.81 billion in revenue from these activities. The company operates primarily in the United States and Europe but also has a significant international presence. Gilead Sciences has been actively enhancing its portfolio through strategic alliances and targ
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | GILD | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
GILD alerts
GILD alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
GILD alerts
High impacting Gilead Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GILD
NEWS
NEWS
- Gilead Sciences (GILD) Stock Sinks As Market Gains: Here's Why [Yahoo! Finance][Yahoo! Finance]
- Gilead Sciences, Inc. (NASDAQ: GILD) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $70.00 price target on the stock.[MarketBeat]
- Cell Therapy Manufacturing Market Historical Trends (2022-2023) and Forecasted Estimates (2024-2035) [Yahoo! Finance][Yahoo! Finance]
- Gilead's lenacapavir: HIV prospects strongest in long-acting combos with Merck's islatravir [Yahoo! Finance][Yahoo! Finance]
- Should You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 5.7% Return On Equity? [Yahoo! Finance][Yahoo! Finance]
- More
GILD
SEC Filings
SEC Filings
- 9/13/24 - Form 4
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- GILD's page on the SEC website
- More